Lobe Sciences Ltd. (LOBEF)
OTCMKTS · Delayed Price · Currency is USD
0.0300
-0.0036 (-10.58%)
Aug 6, 2025, 3:53 PM EDT
Exscientia Revenue
In the fiscal year ending August 31, 2024, Lobe Sciences had annual revenue of 136.21K CAD, down -83.80%.
Revenue
136.21K CAD
Revenue Growth
-83.80%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.33M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 136.21K | -704.33K | -83.80% |
| Aug 31, 2023 | 840.53K | - | - |
| Aug 31, 2022 | - | - | - |
| Aug 31, 2021 | - | - | - |
| Aug 31, 2020 | - | - | - |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Spruce Biosciences | 2.91M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
Lobe Sciences News
- 9 days ago - Lobe Sciences Announces $341,425 CAD Private Placement for General Corporate Purposes - Accesswire
- 9 days ago - Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory - Accesswire
- 21 days ago - Lobe Sciences Ltd. Announces Debt Settlement - Accesswire
- 4 weeks ago - Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease - Accesswire
- 7 weeks ago - Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals - Accesswire
- 2 months ago - Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth - Accesswire
- 4 months ago - Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM) - Accesswire
- 4 months ago - Lobe Sciences Provides Corporate Update - Accesswire